Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$9.81 USD
-0.04 (-0.41%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $9.82 +0.01 (0.10%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.03 | 0.00% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 66.67%. Look out for FOLD's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year increase of 120%.
Earnings History
Price & Consensus
Zacks News for FOLD
Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services